BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Biologics

Parse Biosciences Welcomes South Australian Genomics Centre as First Certified Service Provider in Asia-Pacific

Parse Biosciences, a leader in scalable and affordable single-cell sequencing, is delighted to welcome the South Australian Genomics Centre (SAGC)&nbs...

March 24, 2025 | News

VantAI Introduces Neo-1, the First Unified Model for De Novo Molecular Generation and Structure Prediction

Neo-1 is the first model to unify de novo molecular generation and atomic-level structure prediction in a single model, by generating latent representa...

March 24, 2025 | News

Advanced Instruments to Acquire Nova Biomedical, Creating a Global Life Science Tools Powerhouse

Patricia Industries' subsidiary Advanced Instruments, a manufacturer of analytical instruments for the biopharmaceutical and clinical markets, announ...

March 20, 2025 | News

Alphamab Oncology and CSPC’s Anti-HER2 ADC JSKN003 Secures Breakthrough Therapy Designation in China

Alphamab Oncology (stock code: 9966.HK) and CSPC Pharmaceutical Group Co., Ltd. ("CSPC") (Stock Code: 1093.HK) jointly announced that anti-HER2 biparatopic...

March 19, 2025 | News

SOPHiA GENETICS Surpasses Two Million Genomic Profiles Analyzed on AI-Powered Platform

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and leader in data-driven medicine, has reached a historic milestone: more than two million...

March 19, 2025 | News

Chance Pharmaceuticals Secures New Funding to Advance Phase III Trials for CXG87 and Expand Inhalation Therapy Pipeline

Chance Pharmaceuticals ("Chance Pharma"), a clinical-stage biotechnology company dedicated to the research and development of innovative inhalation therapi...

March 18, 2025 | News

Rona Therapeutics Secures FDA IND Clearance for RN0361, Advancing RNAi Therapy for Severe Hypertriglyceridemia

Rona Therapeutics Inc., a global leader in RNA-targeted therapeutics, announced the clearance of an Investigational New Drug (IND) by the U.S. Food and Dru...

March 18, 2025 | News

South Korea’s Galux Inc. Achieves Breakthrough in AI-Driven Antibody Design for Multiple Therapeutic Targets

Pioneering AI technology successfully designs antibodies de novo for six therapeutic targets, including one without an experimentally resolved structure ...

March 18, 2025 | News

Innovent’s SYCUME® Becomes China’s First IGF-1R Antibody Approved for Thyroid Eye Disease

Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality me...

March 17, 2025 | News

Celonic Integrates Merck’s Breez™ Micro-Bioreactor to Advance mAb Development

Celonic Group, a Swiss-Based Quality contract development and manufacturing organization (CDMO), has announced that it is integrating Merck’s Breez&t...

March 13, 2025 | News

Pierre Fabre and RedRidge Bio Partner to Develop Biparatopic Antibody Drug Candidates

Pierre Fabre Laboratories and RedRidge Bio announced an exclusive R&D collaboration and license agreement to identify and develop biparatopic...

March 13, 2025 | News

Telix Pharmaceuticals Develops High-Yield Lead-212 Generator to Advance Targeted Alpha Therapy

Telix Pharmaceuticals Limited announces that it has developed and validated a breakthrough generator technology for the production of lead-212 (212Pb...

March 13, 2025 | News

GC Cell Begins Phase 1 Clinical Trial for CD5 CAR-NK Therapy GCC2005 in T-Cell Lymphomas

GC Cell , under the leadership of CEO Sungyong Won, announced today the initiation of its domestic Phase 1 clinical trial for GCC2005 (AB‑205), a no...

March 13, 2025 | News

Navigating Biologics Development: Strategies for Regulatory Success, CMC Challenges, and Tech Transfer

Click here to Register Now! As the biologics field rapidly evolves, mastering regulatory pathways, process development, and tech transfer is essential for...

March 12, 2025 | News

Stay Connected